
FDA updates labeling for menopausal hormone therapy, removing broad boxed warnings and adding guidance for younger symptomatic patients.
Morgan Ebert is the managing editor of Contemporary OB/GYN.

FDA updates labeling for menopausal hormone therapy, removing broad boxed warnings and adding guidance for younger symptomatic patients.